Literature DB >> 28388372

Protein Delivery in the Intensive Care Unit: Optimal or Suboptimal?

Daren K Heyland1,2, Peter J M Weijs3,4,5,6, Jorge A Coss-Bu7,8, Beth Taylor9, Arnold S Kristof10,11, Grant E O'Keefe12, Robert G Martindale13.   

Abstract

Emerging evidence suggests that exogenous protein/amino acid supplementation has the potential to improve the recovery of critically ill patients. After a careful review of the published evidence, experts have concluded that critically ill patients should receive up to 2.0-2.5 g/kg/d of protein. Despite this, however, recent review of current International Nutrition Survey data suggests that protein in critically ill patients is underprescribed and grossly underdelivered. Furthermore, the survey suggests that most of protein administration comes from enteral nutrition (EN) despite the availability of products and protocols that enhance the delivery of protein/amino acids in the intensive care unit (ICU) setting. While future research clarifies the dose, timing, and composition for exogenous protein administration, as well as identification of patients who will benefit the most, ongoing process improvement initiatives should target a concerted effort to increase protein intake in the critically ill. This assertion follows from the notion that current patients are possibly being harmed while we wait for confirmatory evidence. Further research should also develop better tools to enable bedside practitioners to monitor optimal or adequate protein intake for individual patients. Finally, exploring the effect of combining adequate protein delivery with early mobility and/or resistance exercise in the ICU setting has the greatest potential for improving the functional outcomes of survivors of critical illness and warrants further study.

Entities:  

Keywords:  amino acids; critical illness; enteral nutrition; exercise; intensive care unit; nutritional support; parenteral nutrition; protein; rehabilitation

Mesh:

Substances:

Year:  2017        PMID: 28388372     DOI: 10.1177/0884533617691245

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  6 in total

Review 1.  Current perspective for tube feeding in the elderly: from identifying malnutrition to providing of enteral nutrition.

Authors:  Manpreet S Mundi; Jayshil Patel; Stephen A McClave; Ryan T Hurt
Journal:  Clin Interv Aging       Date:  2018-08-01       Impact factor: 4.458

2.  Optimizing Nitrogen Balance Is Associated with Better Outcomes in Neurocritically Ill Patients.

Authors:  Tae Jung Kim; Soo-Hyun Park; Hae-Bong Jeong; Eun Jin Ha; Won Sang Cho; Hyun-Seung Kang; Jeong Eun Kim; Sang-Bae Ko
Journal:  Nutrients       Date:  2020-10-14       Impact factor: 5.717

Review 3.  Should We Prescribe More Protein to Critically Ill Patients?

Authors:  Daren K Heyland; Renee Stapleton; Charlene Compher
Journal:  Nutrients       Date:  2018-04-07       Impact factor: 5.717

Review 4.  Biomarkers in critical care nutrition.

Authors:  Christian Stoppe; Sebastian Wendt; Nilesh M Mehta; Charlene Compher; Jean-Charles Preiser; Daren K Heyland; Arnold S Kristof
Journal:  Crit Care       Date:  2020-08-12       Impact factor: 9.097

5.  Protein delivery in intermittent and continuous enteral nutrition with a protein-rich formula in critically ill patients-a protocol for the prospective randomized controlled proof-of-concept Protein Bolus Nutrition (Pro BoNo) study.

Authors:  Simona Reinhold; Desirée Yeginsoy; Alexa Hollinger; Atanas Todorov; Lionel Tintignac; Michael Sinnreich; Caroline Kiss; Caroline E Gebhard; Balázs Kovács; Bianca Gysi; Lara Imwinkelried; Martin Siegemund
Journal:  Trials       Date:  2020-08-25       Impact factor: 2.279

6.  A new high protein-to-energy enteral formula with a whey protein hydrolysate to achieve protein targets in critically ill patients: a prospective observational tolerability study.

Authors:  Franziska Tedeschi-Jockers; Simona Reinhold; Alexa Hollinger; Daniel Tuchscherer; Caroline Kiss; Lukas Gantner; Katrin Ledergerber; Sibylle Zimmermann; Jonas Scheuzger; Jan Huber; Martin Siegemund
Journal:  Eur J Clin Nutr       Date:  2021-06-24       Impact factor: 4.016

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.